DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions

Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK
DIfferences in prostate treatment between ROI and Northern Ireland, and measuring patient opinions ( Dr Anna Gavin - North Ireland Cancer Registry, Queens University, Belfast, UK )
13 Nov 2013

The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer

Dr Robert Thomas - Cambridge University Hospitals, UK
The NCRN Pomi-T study: polyphenol rich whole food supplement slows PSA progression in prostate cancer ( Dr Robert Thomas - Cambridge University Hospitals, UK )
12 Nov 2013

Updates on advances and trials from ASCO; geriatric oncology overview

Dr Supriya Mohile - University of Rochester, New York, USA
Updates on advances and trials from ASCO; geriatric oncology overview ( Dr Supriya Mohile - University of Rochester, New York, USA )
8 Nov 2013

Radium-223: A breakthrough in treatment for advanced prostate cancer?

Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK
Radium-223: A breakthrough in treatment for advanced prostate cancer? ( Prof Robert Coleman - Weston Park Hospital, University of Sheffield, UK )
1 Nov 2013

Where next in renal cell cancer with targeted therapies?

Dr Thomas Powles, Dr Victoria Galvis, Dr Marc Matrana, Prof John Wagstaff
Where next in renal cell cancer with targeted therapies? ( Dr Thomas Powles, Dr Victoria Galvis, Dr Marc Matrana, Prof John Wagstaff )
23 Oct 2013

ecancermedicalscience Editor's Choice: Robotic surgery in oncology

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice: Robotic surgery in oncology ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
22 Oct 2013

Opportunity for mobile treatment setting for lymphoedema patients

Rachel Iredale - Tenovus, Cardiff, Wales, UK
Opportunity for mobile treatment setting for lymphoedema patients ( Rachel Iredale - Tenovus, Cardiff, Wales, UK )
3 Oct 2013

Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening

Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK
Comparing the PLCO and ERSPC trials on efficacy of prostate cancer screening ( Prof Jack Cuzick - Wolfson Institute of Preventive Medicine, London, UK )
3 Oct 2013

Androgen blockade and ipilimumab against castration resistant prostate cancer

Dr Karim Fizazi - Institute Gustave Roussy, Paris, France
Androgen blockade and ipilimumab against castration resistant prostate cancer ( Dr Karim Fizazi - Institute Gustave Roussy, Paris, France )
3 Oct 2013

Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013

Prostate-specific antigen test 'does more harm than good'

Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France
Prostate-specific antigen test 'does more harm than good' ( Prof Mathieu Boniol - International Prevention Research Institute, Lyon, France )
29 Sep 2013